<DOC>
	<DOC>NCT01992497</DOC>
	<brief_summary>Effect, tolerance and safety of a supplementation with a probiotic on the risk of gastrointestinal infections, on growth, and on gut microbiota in healthy newborn term infants born by Cesarean section. Exploratory comparison between a probiotic vs. placebo in the formula-fed and in the breastfed feeding groups.</brief_summary>
	<brief_title>Cesarean Section Study</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>written informed consent must be obtained from legal guardian(s) prior to randomization or any study related procedures healthy newborns born by Cesarean section singleton birth Age at enrollment in the study &lt; 24h birth weight ≥ 2500g and ≤ 4300g gestational age ≥ 37 weeks and ≤ 42 weeks congenital diseases or malformations that may inhibit growth prenatal and/or postnatal diseases parents are expected to have difficulty complying with the feeding regime planned readmittance to the hospital in the first 14 days of life antibiotic treatment at the time of enrollment in the study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Hours</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Cesarean section, probiotic, formula fed, gut microbiota</keyword>
</DOC>